Pharming Group Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Pharming Group stock have an average target of 33.5, with a low estimate of 30 and a high estimate of 37. The average target predicts an increase of 344.89% from the current stock price of 7.53.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$33.5	$37	$37
Change	+298.41%	+344.89%	+391.37%	+391.37%

Analyst Ratings

The average analyst rating for Pharming Group stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Carrier Oppenheimer	Oppenheimer	Buy Maintains $31 → $30	Buy	Maintains	$31 → $30	+298.41%	Oct 28, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+391.37%	Oct 24, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+391.37%	Oct 15, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+391.37%	Oct 10, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+391.37%	Sep 26, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

296.56M

from 245.32M

20.89%

from 245.32M

Revenue Next Year

329.63M

from 296.56M

11.15%

from 296.56M

EPS This Year

-0.01

from -0.02

EPS Next Year

-0.01

from -0.01

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jan 1, 2020	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	189.39M	212.17M	198.87M	205.62M	245.32M	296.56M	329.63M	371.47M
Revenue Growth	40.15%	12.03%	-6.27%	3.39%	19.30%	20.89%	11.15%	12.69%
EPS	0.06	0.05	0.02	0.02	-0.02	-0.01	-0.01	0.02
EPS Growth	60.53%	-9.84%	-58.18%	-17.39%	-	-	-	-
Forward PE	-	-	-	-	-	-	-	365.53
No. Analysts	-	-	-	-	-	7	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	306.6M	358.5M	434.0M
Avg	296.6M	329.6M	371.5M
Low	279.0M	302.5M	316.5M

Revenue Growth

Revenue Growth	2024	2025	2026
High	25.0%	20.9%	31.7%
Avg	20.9%	11.2%	12.7%
Low	13.7%	2.0%	-4.0%

EPS Forecast

EPS	2024	2025	2026
High	-0.01	0.04	0.13
Avg	-0.01	-0.01	0.02
Low	-0.01	-0.06	-0.06

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.